Methylphenidate (Ritalin) Production Cost Reports

The report provides a detailed analysis essential for establishing a Methylphenidate (Ritalin) manufacturing plant. It encompasses all critical aspects necessary for Methylphenidate (Ritalin) production, including the cost of Methylphenidate (Ritalin) production, Methylphenidate (Ritalin) plant cost, Methylphenidate (Ritalin) production costs, and the overall Methylphenidate (Ritalin) manufacturing plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Methylphenidate (Ritalin) production plant. These encompass manufacturing processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Methylphenidate (Ritalin) is a drug that has a wide range of applications in the medical and pharmaceutical industries. This drug serves as a synthetic Central Nervous System stimulant that is widely used for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy (sleep disorder). Moreover, the compound also finds its application in reducing and managing hyperactivity and impulsive behavior and increasing attention in patients with ADHD.

The market of Methylphenidate (Ritalin) is largely led by its application in the medical industry as a common psychostimulant for the treatment of attention deficit disorder (ADD) to help with hyperactivity, which significantly boosts its market growth. Moreover, its usage as a drug to increase attention or alertness and treat narcolepsy (daytime sleepiness) further enhances its demand in the medical and pharmaceutical industries. Furthermore, several factors influence industrial methylphenidate (Ritalin) procurement, such as the availability of raw materials (phenylacetonitrile, 2-chloropyridin, etc.), cost and pricing, compliance with pharmaceutical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.

Raw Material for Methylphenidate (Ritalin) Production

According to the Methylphenidate (Ritalin) manufacturing plant project report, the major raw materials for Methylphenidate (Ritalin) production include Phenylacetonitrile - 2-Chloropyridin-Toluene; Benzylcyanide - 2-chloropyridine.

Manufacturing Process of Methylphenidate (Ritalin)

The extensive Methylphenidate (Ritalin) production cost report consists of the following industrial manufacturing process:

• Production through Condensation of Phenylacetonitrile: This method of production involves the condensation of phenylacetonitrile with a 2-chloropyridin by using toluene in the presence of NaNH2 at 110–112°C to form 2-phenyl-2-(pyridin-2-yl)acetonitrile. Further, this compound is hydrolyzed in the presence of sulfuric acid to synthesize the corresponding amide. Then, the obtained amide compound is treated with HCl in the presence of methanol, followed by heating to produce methyl 2-phenyl-2-(pyridin-2-yl)acetate. Further, the reaction propagates with the hydrogenation of the pyridine ring to a piperidine ring in the presence of acetic acid and Pt or PtO2 catalyst to obtain methylphenidate as the desired product.
• Production via Arylation of Benzylcyanide: The arylation of benzylcyanide initiates this method of production by using 2-chloropyridine in the presence of a base, which results in the formation of α-phenyl-α-(2-pyridil) acetonitrile. Further, the nitrile group of the compound is hydrolyzed in the presence of sulfuric acid and simultaneous esterification with methanol to obtain the methyl ester of α-phenyl-α-(2-pyridylacetic acid) or methylphenidate.

Methylphenidate (Ritalin) is a drug much similar in action to Dextroamphetamine. This drug is available in the form of small pills that are off-white to pale yellow in color. The molecular formula of the compound is C14H19NO2, and its molecular weight is 233.31 g/mol. This drug is used as a medication for the treatment of ADHD in childrens. The IUPAC name of the compound is methyl 2-phenyl-2-piperidin-2-ylacetate. Moreover, the melting point of this chemical compound is 224-226°C, and its boiling point is 135 to 137 °C. It is does not dissolve in water but gets its easily dissolved in alcohol, ether, and ethyl acetate. Additionally, the compound releases toxic fumes of nitroxides when it decomposes in the presence of heat.